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Objective: HLA-A*24:287 is a low incidence allele in the HLA-A locus. The objective of this study is to
report the ethnicity of A*24:287 and its deduced probable human leukocyte antigen (HLA)-associated
haplotypes in Taiwanese unrelated bone marrow hematopoietic stem cell donors.
Materials and methods: A sequence-based typing method was employed to conﬁrm the low incidence
allele A*24:287. Polymerase chain reactionwas performed to amplify exon 2 and exon 3 of the HLA-A and
HLA-B loci and exon 2 of the HLA-DRB1 locus using group-speciﬁc primer sets. The amplicons were
sequenced employing BigDye Terminator Cycle Sequencing Ready Reaction kits in both directions ac-
cording to the manufacturer's protocols.
Results: The DNA sequence of A*24:287 is identical to A*24:02:01:01 in exons 2 and 3, except for residue
617 where C is changed to G (codon 182, ACG->AGG). The nucleotide exchange leads to an amino acid
alteration to the protein sequence of A*24:02:01:01 at residue 182 where the threonine of A*24:02:01:01
is changed to the arginine of A*24:287. We deduced the probable HLA haplotypes in association with
A*24:287 in Taiwanese to be A*24:287-B*40-DRB1*15 and A*24:287-B*58-DRB1*03:01.
Conclusion: Information on the deduced probable HLA haplotypes in association with the low incidence
A*24:287 allele that we report here are of value for HLA testing laboratories for reference purposes. In
addition, they can be used by stem cell transplantation donor search coordinators to determine a strategy
for ﬁnding compatible donors in unrelated bone marrow donor registries when a patient has this un-
common HLA allele.
Copyright © 2015, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
New human leukocyte antigen (HLA) alleles continue to be
revealed and the recognition of HLA low incidence alleles has
enriched our understanding of the complexity of the HLA system.
The major histocompatibility complex (MHC) in humans consistsells Centre, Hualien Tzu Chi
ualien, Taiwan. Tel: þ886
elief Tzu Chi Foundation. Publisheof several loci of genes that are located on the short arm of
chromosome 6 at 6p21.3. These loci are classiﬁed into MHC Class I,
Class II, and Class III regions. The genes encoding the HLA alleles
are located in the MHC Class I and Class II regions. HLA genes are
characterized by their extreme allelic polymorphism as well as
their variations and diversity in different ethnic groups and racial
populations. HLA molecules have been deﬁnitely deﬁned as
transplant antigens and have a strong relevance in tissue trans-
plantation. The molecular similarity between donors and re-
cipients is being considered a predictive factor for graft survival
and graft-versus-host disease. It is imperative to precisely char-
acterize any unknown and low incidence alleles encountered
during routine HLA typing procedures. To facilitate successful andd by Elsevier Taiwan LLC. All rights reserved.
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donor searches for patients in need of hematopoietic stem cell
transplantation, persistent efforts are needed to resolve uniden-
tiﬁed, ambiguous or low incidence alleles to offer better HLA
matching and donor selection.
The nucleotide sequence of HLA-A24:287 was ﬁrst submitted
to GenBank (accession number LK021330) and the name HLA-
A24:287 (HWS1002300) was ofﬁcially assigned by the World
Health Organization HLA Nomenclature Committee in June 2014
[1]. However, there was no indication of its ethnicity and its
associated HLA haplotype in the report. Here, we report the
Taiwanese ethnicity of A24*287 and the deduced probable HLA
haplotypes in association with A*24:287 based on the HLA-A, -B,
and -DRB1 alleles commonly shared by the HLA typing of our
donors and a donor (donor ID 360391) submitted to the IMGT
database [1]. We further speculate that the deduced plausible
HLA haplotypes associated with A*24:287 are restricted to
Taiwanese.
2. Materials and methods
Peripheral whole blood samples from unrelated bone marrow
hematopoietic stem cell donors with Taiwanese ethnicity were
collected in acid citrate dextrose anticoagulant. Formal written
consents were signed by the donors before blood collection. The
acid citrate dextrose whole blood samples were stored at 80C
until use. Genomic DNA was extracted using QIAamp DNA Blood
Mini Kits according to the manufacturer's instructions (Qiagen,
Hilden, Germany). The DNA material was subjected to HLA geno-
typing for the HLA-A, HLA-B, and HLA-DRB1 loci using commercial
polymerase chain reaction sequencing-based typing kits (Secore A/
B/DRB1 Locus Sequencing kits, Life Technologies, Brown Deer, WI,
USA). High resolution allelic sequencing was performed as
previously described [2e6]. The two sets of primer sequences used
were: (1) B-CG: M13-BIN1-CGG (sense): TGTAAAACGACGGCCAGFig. 1. (A) The DNA sequence of A*24:287 is identical to A*24:02:01:01 in exons 2 and 3, exc
the G (shaded) of A*24:287. Exon 2 and exon 3 are separated by two vertical lines between n
exchange at codon 182 where the threonine of A*24:02:01:01 is replaced by the argin
A*24:02:01:01.TCGGGGGCGCAGGACCCGG; P3'exon 5B (antisense): GCTCCGAT-
GACCACAACTGCT; and (2) B-TA: M13-BIN1-TGA (sense):
TGTAAAACGACGGCCAGTGGCGGGGGCGCAGGACCTGA; P3'exon 5B
(antisense): GCTCCGATGACCACAACTGCT. The amplicons were
sequenced using a BigDye Terminator Cycle Sequencing Ready
Reaction kit (Applied Biosystems, Foster City, CA, USA) in both di-
rections. The HLA allele-associated probable haplotypes postulated
in this study were determined by looking at the commonly shared
HLA typing of the donors carrying A*24:287. Where applicable,
haplotype deduction based on HLA allelic homozygosity is as
described previously [7,8]. For example, if a donor is typed for HLA-
A, -B and -DRB1 as having A*33:03, -, B*58:01, -, DRB1*03:01, -, it is
possible to deduce the putative haplotypes of the donor derived
from the biological parents as HLA-A*33:03-B*58:01-DRB1*03:01
and A*33:03-B*58:01-DRB1*03:01, respectively. Also, if the typing of
a donor is A*02:01, A*02:07, B*46:01, -, DRB1*09:01, -, the putative
haplotypes of the donor are A*02:01-B*46:01-DRB1*09:01 and
A*02:07-B*46:01-DRB1*09:01 [8].3. Results
We conﬁrmed that the DNA sequence of A*24:287 is identical
to A*24:02:01:01 in exon 2 and exon 3, except for residue 617
where C is changed to G (codon 182, ACG->AGG) (Fig. 1). The
nucleotide replacement causes a one amino acid alteration to the
protein sequence of A*24:02:01:01 at residue 182 where the
threonine of A*24:02:01:01 is replaced by the arginine of
A*24:287. The extended HLA-A, -B and -DRB1 typing of our donors
with A*24:287 is shown in Table 1. Together with the HLA typing
(A*02, A*24:287, B*40, B*67, DRB1*15 and DRB1*16) of the cell
(D360391) submitted to the IMGT/HLA database [1], we deduced
the two probable HLA haplotypes in association with A*24:287 in
our Taiwanese donors as A*24:287-B*40-DRB1*15 and A*24:287-
B*58-DRB1*03:01.ept at residue 617 (codon 182; underlined), where the C of A*24:02:01:01 is changed to
ucleotide 343 and nucleotide 344. (B) The nucleotide exchange causes a one amino acid
ine (shaded) of A*24:287. Dashes indicate nucleotide or amino acid identity with
Table 1
HLA-A, -B, and -DRB1 alleles of donors with A*24:287 and deduced probable HLA-A-B-DRB1 haplotypes associated with A*24:287.
Donor HLA-A* HLA-B* HLA-DRB1* Deduced probable A*24:287 associated HLA haplotypes
Donor 1 24:287 11 15 40 12 15 A*24:287-B*40-DRB1*15
Donor 2 24:287 24 54 40 4:05:01 15 A*24:287-B*40-DRB1*15
Donor 3 24:287 33 58 e 03:01 e A*24:287-B*58-DRB1*03:01
IMGT 360391 24:287 02 67 40 16 15 A*24:287-B*40-DRB1*15
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We conﬁrmed the DNA sequence and amino acid sequence of
the HLA allele A*24:287 in this study. A*24:287 was initially
detected in an individual from Taiwan (with HLA typing of A*02,
A*24:287, B*40, B*67, DRB1*15, and DRB1*16) [1]. We deduced the
two probable A*24:287-associated HLA haplotypes to be A*24:287-
B*40-DRB1*15 and A*24:287-B58-DRB1*0301, based on the
commonly shared HLA typing of three donors carrying A*24:287 (1
of them with HLA-B and -DRB1 homozygosity; A*24:287, A*33,
B*58, and DRB1*03:01) listed in our registry and the donor infor-
mation submitted to the IMGT (D360391) (Table 1). We further
speculate that individuals bearing the A*24:287 allele are probably
Taiwanese, since the donors carrying A*24:287 in our registry and
the donor (D360391) with A*24:287 reported to the IMGT/HLA
database [1] are all Taiwanese.
It is worth mentioning that the most direct and classic method
to determine HLA haplotype is through family study if test mate-
rials from a number of key family members are available. Alterna-
tively, a population study may be employed if a signiﬁcant number
of unrelated donors is available [2]. However, the haplotypes
deduced via population investigation are considered likely or most
probable. In this study, because of the lack of availability of
necessary test materials from the families of the donors with
A*24:287, we opted to determine the haplotype by looking at the
HLA alleles carried in common by unrelated donors bearing the
same alleles of interest. Also, if determination of plausible HLA
haplotypes is for rare or low frequency HLA alleles, the alleles
shared in common by unrelated individuals may be employed to
deduce associated probable haplotypes [3e6,9e12].
The frequency of A*24:287 in Taiwanese is about one in 40,000
according to our HLA typing practice. To date, the Allele Frequency
Net Database (http://www.allelefrequencies.net/hla6006a.asp?
hla_locus_type¼Classical#) has yet to show the existence of the
allele in the world population. Therefore, we think the probable
A*24:287-associated HLA haplotypes in Taiwanese that we
deduced in this study are highly accountable.
The signiﬁcance of determining the ethnicity of individuals with
A*24:287 and its HLA linked haplotypes is that the informationmay
be employed in anthropological investigation of races in addition to
allowing search coordinators in unrelated bone marrow donor
registries to allocate appropriate unrelated bone marrow hemato-
poietic stem cell donors for their patients.
The numbers of known HLA alleles are increasing exponentially
with the recent development of DNA-based molecular typing
technology. Understanding HLA diversity in ethnic groups is
important. Facilitating an appropriate HLA-matched unrelated
bone marrow stem cell donor for successful stem cell trans-
plantations relies on the accuracy of HLA typing and the determi-
nation to resolve unknown, ambiguous, and low incidence genes in
the HLA system. Additionally, determination of haplotypes isessential for matching in unrelated stem cell transplantation be-
tween donor and recipient, since matching at the haplotype level
has a better likelihood of matching at other loci within the HLA
region than that for donors merely matched at the individual allelic
level.
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